Rofecoxib [Vioxx, MK-0966; 4-(4′-Methylsulfonylphenyl)-3-phenyl-2-(5 H)-furanone]: A Potent and Orally Active Cyclooxygenase-2 Inhibitor. Pharmacological and Biochemical Profiles

This publication has 26 references indexed in Scilit:

• NS-398, a novel non-steroidal anti-inflammatory drug with potent analgesic and antipyretic effects, which causes minimal stomach lesions
  Published by Elsevier ,2002
• Characterization of autocrine inducible prostaglandin H synthase-2 (PGHS-2) in human osteosarcoma cells
  Inflammation Research, 1997
• Selective inhibition of cyclooxygenase-1 and -2 using intact insect cell assays
  Biochemical Pharmacology, 1996
• Mechanism of selective inhibition of human prostaglandin G/H synthase-1 and -2 in intact cells
  Biochemical Pharmacology, 1996
• Human whole blood assays for inhibition of prostaglandin G/H synthases-1 and-2 using A23187 and lipopolysaccharide stimulation of thromboxane B2 production
  Inflammation Research, 1996
• A human whole blood assay for clinical evaluation of biochemical efficacy of cyclooxygenase inhibitors
  Inflammation Research, 1996
• Inhibition of constitutive and inducible cyclooxygenase activity in human platelets and mononuclear cells by NSAIDS and Cox 2 inhibitors
  Inflammation Research, 1995
• Effects of Nonsteroidal Antiinflammatory Drugs on Platelet Function and Systemic Hemostasis
  The Journal of Clinical Pharmacology, 1995
• New insights into the mode of action of anti-inflammatory drugs
  Inflammation Research, 1995
• Radiologic analysis of arthritis in rats after systemic injection of streptococcal cell walls
  Arthritis & Rheumatism, 1979